<?xml version="1.0" encoding="utf-8" ?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>ACELRX PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.net</title><description>www.finanzen.net bietet Finanznachrichten zum weltweiten Börsengeschehen</description><category>Finanzen</category><link>https://www.finanzen.net</link><language>de-de</language><copyright>finanzen.net GmbH</copyright><lastBuildDate>Sat, 02 May 2026 21:06:01 +0200</lastBuildDate><atom:link href="https://www.finanzen.net/rss/acelrx%5Fpharmaceuticals%5F1%2Drss%2Dfeed" rel="self" type="application/rss+xml"/><image><url>https://images.finanzen.net/images/finanzen_net_neu.gif</url><title>ACELRX PHARMACEUTICALS 1 RSS Feed | Nachrichten - www.finanzen.net</title><link>https://www.finanzen.net</link></image><item><title>AcelRx Pharmaceuticals: Bilanzzahlen zum vergangenen Quartal</title><pubDate>Wed, 25 Mar 2026 06:35:07 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/acelrx-pharmaceuticals-bilanzzahlen-zum-vergangenen-quartal-15574992</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/acelrx_pharmaceuticals_1-aktie">AcelRx Pharmaceuticals</a> ließ sich am 23.03.2026 in die Bücher schauen: Auf der vierteljährlichen Finanzkonferenz hat AcelRx Pharmaceuticals die Bilanz zum am 31.12.2025 beendeten Jahresviertel offengelegt.Das  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/acelrx-pharmaceuticals-bilanzzahlen-zum-vergangenen-quartal-15574992</guid></item><item><title>AcelRx Pharmaceuticals stellte das Zahlenwerk zum vergangenen Quartal vor</title><pubDate>Fri, 14 Nov 2025 06:35:06 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/acelrx-pharmaceuticals-stellte-das-zahlenwerk-zum-vergangenen-quartal-vor-15275196</link><description><![CDATA[<p><a href="https://www.finanzen.net/aktien/acelrx_pharmaceuticals_1-aktie">AcelRx Pharmaceuticals</a> hat am 12.11.2025 die Geschäftsergebnisse zum jüngsten Jahresviertel vorgestellt.Das EPS lag bei -0,11 USD. Ein Jahr zuvor waren -0,130 USD je Aktie erzielt worden.Redaktion  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/acelrx-pharmaceuticals-stellte-das-zahlenwerk-zum-vergangenen-quartal-vor-15275196</guid></item><item><title>Talphera Announces Third Quarter 2025 Financial Results and Provides Corporate Update</title><pubDate>Wed, 12 Nov 2025 22:05:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/talphera-announces-third-quarter-2025-financial-results-and-provides-corporate-update-15268821</link><description><![CDATA[<p><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><i>Closed <span class="xn-money">$17 million first tranche financing led by a strategic investment from CorMedix, Inc. </i><p class="prntac" xmlns="http://www.w3.org/1999/xhtml"><i>Cash and investments  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/talphera-announces-third-quarter-2025-financial-results-and-provides-corporate-update-15268821</guid></item><item><title>Talphera to Host Third Quarter Financial Results and Corporate Update Call and Webcast on Wednesday, November 12, 2025</title><pubDate>Wed, 05 Nov 2025 22:05:00 +0100</pubDate><link>https://www.finanzen.net/nachricht/aktien/talphera-to-host-third-quarter-financial-results-and-corporate-update-call-and-webcast-on-wednesday-november-12-2025-15200145</link><description><![CDATA[<p><p xmlns="http://www.w3.org/1999/xhtml"><span class="legendSpanClass"><span class="xn-location">SAN MATEO, Calif., <span class="legendSpanClass"><span class="xn-chron">Nov. 5, 2025 /PRNewswire/ -- Talphera, Inc. (Nasdaq: TLPH), ("Talphera"), a specialty  ...</p>]]></description><guid isPermaLink="true">https://www.finanzen.net/nachricht/aktien/talphera-to-host-third-quarter-financial-results-and-corporate-update-call-and-webcast-on-wednesday-november-12-2025-15200145</guid></item></channel></rss>
